A novel variant in the COL4A3 gene: etiology of Alport syndrome type 2 in a 38-year-old male with suspected hereditary kidney disease

• Published in: Advances in laboratory medicine 2021, Vol.2 (3), p.451-462
• Main Authors: Sienes Bailo, Paula, Bancalero Flores, José Luis, Lahoz Alonso, Raquel, Santamaría González, María, Gutiérrez Dalmau, Alex, Álvarez de Andrés, Sara, Izquierdo Álvarez, Silvia
• Format: Report
• Language: eng ; spa
• ISSN: 2628-491X
• DOI: 10.1515/almed-2021-0058

ObjectivesPatients with Alport syndrome develop progressive kidney function deterioration, sensorineural hearing loss, and ocular abnormalities. This condition is caused by mutations in COL4A5 (X-linked inheritance), COL4A3 and COL4A4 (autosomal dominant or recessive inheritance), and encoding type IV collagen α3, α4, and α5, respectively. If left untreated, clinical symptoms progress from microscopic hematuria to proteinuria, progressive kidney failure, and end-stage kidney disease. At present, kidney transplantation is the only effective approach. Next-generation sequencing is the method of choice for the diagnosis of this condition. Case presentationWe report the case of a young man with chronic kidney disease who eventually underwent transplantation. Molecular testing made it possible to determine the etiology of his clinical symptoms and autosomal recessive Alport syndrome type 2. The patient was found to be a compound heterozygote for two missense variants (trans configuration) in the COL4A3 gene: A likely pathogenic variant c.4981C>T (p.Arg1661Cys) in exon 52 inherited from the mother (described elsewhere), and another variant of uncertain significance, c.943G>A (p.Gly315Ser), in exon 17 inherited from the father that has not been previously reported in the literature or found in relevant databases. ConclusionsFollowing genetic confirmation, genetic counseling was provided to the patient and his direct relatives.